1. Home
  2. APLT vs CEV Comparison

APLT vs CEV Comparison

Compare APLT & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • CEV
  • Stock Information
  • Founded
  • APLT 2016
  • CEV 1999
  • Country
  • APLT United States
  • CEV United States
  • Employees
  • APLT N/A
  • CEV N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • CEV Finance/Investors Services
  • Sector
  • APLT Health Care
  • CEV Finance
  • Exchange
  • APLT Nasdaq
  • CEV Nasdaq
  • Market Cap
  • APLT 63.6M
  • CEV 69.7M
  • IPO Year
  • APLT 2019
  • CEV N/A
  • Fundamental
  • Price
  • APLT $0.41
  • CEV $9.99
  • Analyst Decision
  • APLT Buy
  • CEV
  • Analyst Count
  • APLT 6
  • CEV 0
  • Target Price
  • APLT $6.10
  • CEV N/A
  • AVG Volume (30 Days)
  • APLT 771.9K
  • CEV 19.6K
  • Earning Date
  • APLT 11-06-2025
  • CEV 01-01-0001
  • Dividend Yield
  • APLT N/A
  • CEV 4.23%
  • EPS Growth
  • APLT N/A
  • CEV N/A
  • EPS
  • APLT N/A
  • CEV 0.36
  • Revenue
  • APLT $121,000.00
  • CEV N/A
  • Revenue This Year
  • APLT N/A
  • CEV N/A
  • Revenue Next Year
  • APLT $5,931.24
  • CEV N/A
  • P/E Ratio
  • APLT N/A
  • CEV $29.36
  • Revenue Growth
  • APLT N/A
  • CEV N/A
  • 52 Week Low
  • APLT $0.30
  • CEV $8.83
  • 52 Week High
  • APLT $10.62
  • CEV $10.91
  • Technical
  • Relative Strength Index (RSI)
  • APLT 38.50
  • CEV 75.35
  • Support Level
  • APLT $0.40
  • CEV $9.89
  • Resistance Level
  • APLT $0.46
  • CEV $10.01
  • Average True Range (ATR)
  • APLT 0.03
  • CEV 0.07
  • MACD
  • APLT -0.01
  • CEV 0.05
  • Stochastic Oscillator
  • APLT 7.74
  • CEV 83.08

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.

Share on Social Networks: